Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/41761
Title: The tyrosine kinase Lyn limits the cytokine responsiveness of plasma cells to restrict their accumulation in mice.
Authors: Infantino S.;Peperzak V.;Phesse T.;Ernst M.;Mackay F.;Hibbs M.L.;Fairfax K.A.;Tarlinton D.M.;O'Donnell K.;Light A.;Tsantikos E.;Maxwell M.J.;Walker J.A.;Jones S.A.
Institution: (Infantino, Jones, Walker, Light, O'Donnell, Peperzak, Phesse, Ernst, Fairfax, Tarlinton) Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia (Infantino, Jones, Walker, Light, O'Donnell, Peperzak, Phesse, Ernst, Fairfax, Tarlinton) Department of Experimental Medicine, University of Melbourne, Parkville, VIC 3052, Australia (Jones) Centre for Inflammatory Diseases, Southern Clinical School, Monash Medical Centre, Clayton, VIC 3800, Australia (Maxwell, Tsantikos, Mackay, Hibbs, Fairfax) Department of Immunology, Alfred Medical Research and Education Precinct, Monash University, Commercial Road, Melbourne, VIC 300, Australia
Issue Date: 13-Sep-2014
Copyright year: 2014
Publisher: American Association for the Advancement of Science
Place of publication: United States
Publication information: Science Signaling. 7 (338) (no pagination), 2014. Article Number: ra77. Date of Publication: 12 Aug 2014.
Journal: Science Signaling
Abstract: Maintenance of an appropriate number of plasma cells, long-lived antibody-producing cells that are derived from B cells, is essential formaintaining immunological memory while limiting disease. Plasma cell survival relies on extrinsic factors, the limited availability of which determines the size of the plasma cell population. Mice deficient in the nonreceptor tyrosine kinase Lyn are prone to an autoimmune disease that is characterized by inflammation and an excess of plasma cells (plasmacytosis). Wedemonstrated that the plasmacytosis was intrinsic to B cells and independent of inflammation. We also showed that Lyn attenuated signaling by signal transducer and activator of transcription 3 (STAT3) and STAT5 in response to the cytokines interleukin-6 (IL-6) and IL-3, respectively, in two previously uncharacterized plasma cell signaling pathways. Thus, in the absence of Lyn, the survival of plasma cells was improved, which enabled the plasma cells to become established in excess numbers in niches in vivo. These data identify Lyn as a key regulator of survival signaling in plasma cells, limiting plasma cell accumulation and autoimmune disease susceptibility.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1126/scisignal.2005105
PubMed URL: 25118329 [http://www.ncbi.nlm.nih.gov/pubmed/?term=25118329]
ISSN: 1945-0877
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/41761
Type: Article
Appears in Collections:Articles

Show full item record

Page view(s)

12
checked on Oct 6, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.